Replimune's Skin Cancer Drug Faces Another FDA Rejection
Replimune's cancer drug candidate has been rejected by the FDA for the second time, raising questions and discussions within the medical community.
12 articles tagged with "cancer"
Replimune's cancer drug candidate has been rejected by the FDA for the second time, raising questions and discussions within the medical community.
Recent research indicates that signals from gut bacteria and their metabolites could be instrumental in the early detection of serious digestive diseases, including cancer.
Strategic angle: A breakthrough in targeting cancer cells without harming healthy tissue using synthetic DNA strands.
Strategic angle: A breakthrough in treating one of the most challenging cancers using innovative lipid nanoparticles.
Strategic angle: Exploring the impact of chemotherapy on RNA integrity and its implications for cellular function.
Strategic angle: A new type of protein modification related to cellular mutation could enhance cancer treatment options.
Strategic angle: Engineered probiotics infiltrate tumors to produce targeted cancer-fighting drugs.
Strategic angle: A redesigned cancer immunotherapy shows promising early results, potentially changing the landscape of cancer treatment.
Strategic angle: Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors using milk-derived nanoparticles.
Strategic angle: Scientists have discovered that cells can sense far beyond the surfaces they touch, shedding light on cancer cell behavior.
Strategic angle: A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized.
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.